IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
HPC Biosciences IPO is a Fixed Price listing on BSE SME exchange, with an ipo size of ₹ 15.75 Cr. The company is based in New Delhi and caters to Agro sector. Guiness Corporate Advisors is the merchant banker of HPC Biosciences IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 17th January 2013.
HPC Biosciences IPO posted revenues of ₹ 8.74 crores and PAT of ₹ 7.08 crores in FY13 on annualised basis.
Revenue:
₹ 5.46 Cr.
EBITDA Margin:
86.54
% 
Net Worth: ₹ 7.75 Cr.
Market Capitalisation:
[●]
P/E:
8.00 times
P/BV: [●]
EV/EBITDA: -0.09 times
Financial results of HPC Biosciences IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Nov-12 | FY12 | FY11 | FY10 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 7.75 | 4.79 | 0.08 | 0.08 | |
| Net Worth | 7.75 | 4.79 | 0.05 | 0.05 | |
| Total Debt | [●] | [●] | 0.03 | 0.03 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
3.64
5.46 |
2.89 | [●] | [●] | |
EBITDA
EBITDA on annualised basis |
3.15
4.73 |
3.17 | [●] | [●] | |
PAT
PAT on annualised basis |
2.95
4.43 |
3.04 | [●] | [●] | |
HPC Biosciences IPO PAT Margin is 81.04 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows HPC Biosciences IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Nov-12 | FY12 | FY11 | FY10 |
|---|---|---|---|---|
| EBITDA Margin (%) | 86.54 | 109.69 | [●] | [●] |
| PAT Margin (%) | 81.04 | 105.19 | [●] | [●] |
| EPS (₹) | 3.96 | 4.66 | [●] | [●] |
| ROE (%) | 38.06 | 63.47 | [●] | [●] |
| ROCE (%) | [●] | [●] | [●] | [●] |
| ROA (%) | 38.06 | 63.47 | [●] | [●] |
| Debt to Equity | [●] | [●] | 0.60 | 0.60 |
The market Capitalisation of HPC Biosciences IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The HPC Biosciences IPO prospectus highlights an Return on Equity (ROE) of 38.06 % , Return on Assets (ROA) of 38.06 %, and an EBITDA Margin of 86.54 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows HPC Biosciences IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of HPC Biosciences IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The HPC Biosciences IPO has a Price-to-Earnings (PE) ratio of 8.00 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
HPC Biosciences IPO reported revenue of ₹ 8.74 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from HPC Biosciences IPO provide insights into sales growth, market demand, and business scalability.
HPC Biosciences recorded an EBITDA of ₹ 4.73 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
HPC Biosciences Profit After Tax (PAT) is ₹ 4.43 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 5.46 Cr.
EBITDA Margin:
86.54
%
Net Worth: ₹ 7.75 Cr.
Market Capitalisation:
[●]
P/E:
8.00 times
P/BV: [●]
EV/EBITDA: -0.09 times
HPC Biosciences operates in Agro and Agriculture Operations Of Cultivation Processing And Distribution Of Agriculture. The Issue is listed on BSE SME in Mar, 2013. HPC Biosciences IPO size was 15.75 with Issue price of 35.00 .
Merchant Banker(s) of HPC Biosciences IPO: Guiness Corporate Advisors Private Limited
HPC Biosciences IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
HPC Biosciences IPO listed at a listing price of 39.10 against the offer price of 35.00.
The current market price of HPC Biosciences is 26.20.
Why Us?
